Cargando…
Safety and Efficacy of Tree Pollen Specific Immunotherapy on the Ultrarush Administration Schedule Method Using Purethal Trees
Background. Specific immunotherapy (SIT) with an ultrarush administration schedule with Purethal for tree pollen allergens has been evaluated to assess its efficacy and safety. Methods. The study group consisted of 22 patients with symptoms of allergic rhinitis and confirmed allergy to tree pollens....
Autores principales: | Bozek, Andrzej, Kolodziejczyk, Krzysztof, Jarzab, Jerzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982251/ https://www.ncbi.nlm.nih.gov/pubmed/24783221 http://dx.doi.org/10.1155/2014/707634 |
Ejemplares similares
-
Twenty years’ observation of subcutaneous pollen allergoid immunotherapy efficacy in adults
por: Bożek, Andrzej, et al.
Publicado: (2017) -
Ultrarush schedule of subcutaneous immunotherapy with modified allergen extracts is safe in paediatric age
por: Morais-Almeida, Mário, et al.
Publicado: (2016) -
Induction of Specific Immunotherapy with Hymenoptera Venoms Using Ultrarush Regimen in Children: Safety and Tolerance
por: Köhli-Wiesner, Alice, et al.
Publicado: (2012) -
Hymenoptera Venom Immunotherapy: Tolerance and Efficacy of an Ultrarush Protocol versus a Rush and a Slow Conventional Protocol
por: Patella, Vincenzo, et al.
Publicado: (2012) -
Ultrarush immunotherapy with polymerized extracts during the coronavirus disease 2019 pandemic: Safety of restarting administrations without dose adjustments
por: Bragança, Mariana, et al.
Publicado: (2022)